COMMUNIQUÉS West-GlobeNewswire

ProMIS Neurosciences Completes First Closing of Private Placement

09/08/2017 - 19:51

/NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, ONTARIO - August 9, 2017 - ProMIS Neurosciences Inc. ("ProMIS" or the "Company") (TSX:PMN; OTCPK:ARFX.F; DB:23J) is [...]

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2017

09/08/2017 - 17:33

Communiqué de presse Villepinte, le 9 août 2017 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]

Stabilization period begins

09/08/2017 - 16:12

Zealand Pharma A/S has today received notification regarding the beginning of the stabilization period Copenhagen, August 9, 2017 - With reference to company announcement no. 31/2017 dated August 9, 2017 regarding the [...]

Shire plc : Director/PDMR Shareholding

09/08/2017 - 15:15

Director/PDMR Shareholding August 9, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transaction by person discharging managerial responsibilities and person closely associated with them 1. Details of the [...]

Merus to Present at the 2017 Wedbush PacGrow Healthcare Conference

09/08/2017 - 13:00

UTRECHT, The Netherlands, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that [...]

AC IMMUNE REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS

09/08/2017 - 12:44

Strong cash position of CHF 124.2 million provides resources to advance pipeline of seven therapeutic and three diagnostic candidates Increased R&D investment across three pillars of Alzheimer`s disease, neuro- [...]

Tecan schedules conference call on August 16th to discuss half year 2017 financial results

09/08/2017 - 10:15

Männedorf, Switzerland, August 9, 2017 - The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to discuss the financial results for the first half year 2017 on Wednesday, August 16th, 2017 at 10:00 [...]

Italy's First Center of Robotic Excellence Established in Northern Italy at Villa Beretta Centro di Riabilitazione

09/08/2017 - 09:00

FREIBURG, Germany and RICHMOND, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- "Villa Beretta" Centro di Riabilitazione, in Costa Masnaga (LC), Italy, has been established as the first Center of Robotic Excellence in Europe [...]

Le premier Centre d'excellence robotique d'Italie a été installé au nord de l'Italie, dans le centre de Villa Beretta Centro di Riabilitazione

09/08/2017 - 09:00

FRIBOURG, Allemagne et RICHMOND, Californie, le 9 août 2017 (GLOBE NEWSWIRE) - « Villa Beretta » Centro di Riabilitazione (centre de rééducation) situé à Costa Masnaga (LC), Italie, a été reconnu comme le premier Centre [...]

Novo Nordisk increased reported operating profit by 8% in the first six months of 2017

09/08/2017 - 07:30

Sales increased by 4% measured in Danish kroner Sales increased by 4% in Danish kroner and by 3% in local currencies to DKK 57.1 billion. Sales of Tresiba ® increased by 155% to DKK 3.7 billion (149% in local currencies [...]

Mithra Pharmaceuticals: RECRUITMENT COMPLETED IN ESTELLE® POPULATION PK SUBSTUDY

09/08/2017 - 07:30

PRESS RELEASE ReCRUITMENT COMPLETED IN Estelle® population PK substudy Study to determine impact of demographic characteristics on the absorption, distribution and excretion of Estelle® PK study is part of the Estelle® [...]

Corbion first half 2017 results

09/08/2017 - 07:00

Corbion reported H1 2017 sales of € 461.9 million, an increase of 1.4% compared to H1 2016. Organic sales growth was -0.9%, mostly due to lower volumes in Bakery. EBITDA excluding one-off items in H1 2017 decreased by 1 [...]

Biocartis Group NV: Invitation to the extraordinary shareholders' meeting

09/08/2017 - 07:00

PRESS RELEASE: REGULATED INFORMATION Wednesday, 9 August 2017, 07:00 CEST Invitation to the extraordinary shareholders' meeting Mechelen, Belgium, 9 August 2017 - Biocartis Group NV (the 'Company' or 'Biocartis'), an [...]

Zealand Pharma A/S prices its initial public offering of American Depositary Shares on The Nasdaq Global Select Market in the United States

09/08/2017 - 02:14

Company announcement - No. 31/2017 Zealand Pharma A/S prices its initial public offering of American Depositary Shares on The Nasdaq Global Select Market in the United States In continuation of Zealand Pharma A/S' [...]

Zealand Pharma A/S exercises its authorization granted by its extraordinary general meeting held on July 31, 2017

09/08/2017 - 00:11

Company announcement - No. 30/2017 Zealand Pharma A/S exercises its authorization granted by its extraordinary general meeting held on July 31, 2017 in connection with its initial public offering of American Depositary [...]

Prothena Reports Second Quarter 2017 Financial Results and Provides R&D Update

08/08/2017 - 22:05

Net cash used in operating and investing activities was $36.3 million in the second quarter and $76.5 million for the first six months of 2017; quarter-end cash and restricted cash position of $475.8 million, provides [...]

Novavax Reports Second Quarter 2017 Financial Results

08/08/2017 - 22:05

GAITHERSBURG, Md., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced its financial results for the second quarter and six months ended June 30, 2017. Second Quarter and Subsequent [...]

Sanofi Files Suit in the U.S. to Defend its Patent Rights on Lantus®

08/08/2017 - 21:31

Sanofi Files Suit in the U.S. to Defend its Patent Rights on Lantus ® Paris, France - August 8, 2017 - Sanofi announced today that it filed a patent infringement suit against Merck Sharp & Dohme Corp. ("Merck") on [...]

Sanofi intente une action en justice aux Etats-Unis pour défendre les brevets de Lantus®

08/08/2017 - 21:31

Sanofi intente une action en justice aux Etats-Unis pour défendre les brevets de Lantus ® Paris, France - Le 8 août 2017 - Sanofi annonce aujourd'hui avoir intenté le 8 août 2017 une action en contrefaçon contre Merck [...]